Parameters NVP group n=24 EFV group n=176 PI group n=160 p
Age (years)* 43 (38-46) 42 (38-44) 42 (39-44) 0.5
Male gender, no. (%) 19 (79) 141 (80) 131 (82) 0.9
CDC C category, no. (%) 6 (27) 67 (38) 62 (39) 0.6
Former IDU, no. (%) 20 (83) 149 (85) 139 (87) 0.8
Hbs Ag positive, no. (%) 0 (0) 2 (1.1) 4 (3) 0.6
HCV genotype 1-4, no. (%) 17 (71) 119 (68) 102 (64) 0.6
Liver fibrosis stage ≥ F3, no. (%)† 5 (46) 33 (49) 44 (57) 0.6
Cirrhosis, no. (%)† 3 (27) 15 (22) 26 (33) 0.3
CD4 cell counts (cells/mm3)* 609 (366-730) 514 (379-660) 483 (315-711) 0.3
Undetectable HIV viral load, no. (%) 23 (96) 157 (89) 141 (88) 0.5
Table 1: Main features of the three treatment groups. Main features of the three treatment groups.